Fusion energy has cleared one historic hurdle after another — most famously in 2022, when the National Ignition Facility produced a reaction with positive energy gain. But a new paper from MIT argues the industry now faces a different kind of problem: not whether fusion can work, but whether it can make money.

In "Criteria for the economic viability of fusion power plants," published in the Journal of Fusion Energy, MIT professors Dennis Whyte and Andrew W. Lo propose a framework built around what they call "economic Q" — the ratio of capital gained to capital expended. It is a deliberate echo of the Lawson criterion, the 1950s formula that describes the temperature, density and confinement time needed for a plasma to produce net energy.

"It's all the things that come along with finding, allocating, and spending money at this scale," says Whyte, a professor of nuclear science and engineering who co-founded Commonwealth Fusion Systems. "If we want this technology to actually be meaningful in the world economy, we have to start getting straight with ourselves about these topics."

The framework uses ten parameters, most of them engineering and financial rather than physical: power density, the efficiency of converting fusion power into an economic product, component durability, construction costs, and market returns. The authors stress the method is "completely agnostic" to the fusion concept used — magnetic confinement, lasers or anything else — because every approach ultimately comes down to the same arithmetic: money out must exceed money in.

Whyte and Lo also co-founded Rutherford Energy Ventures, a consultancy working with the U.S. Department of Energy's Oak Ridge National Laboratory on a new fusion research consortium. The timing is deliberate: just last week, Commonwealth Fusion Systems closed a new billion-dollar funding round as it works toward a first power plant in Virginia in the 2030s.

Lo, an MIT Sloan finance professor, argues that deep-tech industries follow a "learning by doing" curve — sequencing a human genome is now roughly a million times cheaper than it was 25 years ago — and fusion could follow the same path once the first plants are built. The framework, he says, "tells you about the literal worth of making a particular design decision. That seems to me at this moment of fusion development absolutely critical, and what we've been missing."